STOCK TITAN
  1. Home
  2. Financials
  3. RANI
  4. EPS (Diluted)

Rani Therapeutics Holdings, Inc. (RANI) EPS by Year

RANI

Rani Therapeutics Holdings, Inc. lost $0.45 per diluted share in fiscal year 2025. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $0.15 per diluted share. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Rani Therapeutics Holdings, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.45
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RANI EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
EPS (Diluted)-$0.15-$0.45-$1.05+21.1%-$1.33-3.9%-$1.28-197.7%-$0.43N/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

RANI EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.04-$0.04$0.05+118.5%-$0.12-$0.18+30.8%-$0.22+24.1%-$0.27+88.7%-$0.24+33.3%-$0.26+29.7%-$0.29+12.1%-$2.39-582.9%-$0.36-209.1%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Rani Therapeutics Holdings, Inc. financials

Frequently Asked Questions

What was Rani Therapeutics Holdings, Inc.'s diluted earnings per share in fiscal year 2025?

Rani Therapeutics Holdings, Inc. lost $0.45 per diluted share in fiscal year 2025.

What is Rani Therapeutics Holdings, Inc.'s diluted earnings per share over the last twelve months?

Rani Therapeutics Holdings, Inc. (RANI) reported a loss of $0.15 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

What was Rani Therapeutics Holdings, Inc.'s diluted earnings per share in the most recent quarter?

Rani Therapeutics Holdings, Inc. (RANI) reported -$0.04 in diluted earnings per share in Q2 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Rani Therapeutics Holdings, Inc. (RANI) reported on that line in every period on record.